Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase have?
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase has 663 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase published?
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase has 2021 year in the ScholarIQ index.
What is the open-access status of Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase?
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase has green oa status in the ScholarIQ index.
What is the DOI of Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase?
The DOI for Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase is on the source record.
What is the PMID of Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase?
The PMID for Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase is on the source record.
What is the OpenAlex record for Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase?
The OpenAlex for Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase is on the source record.